Australia, June 23 -- Liro Therapeutics Pty. Ltd., owns the trademark (2603567) for 'LIRO THERAPEUTICS' till Nov. 13, 2035.
Status: registered:
Registered/protected
Classes: 35 [Business management, organisation and administration; strategic development, management and implementation of business plans for the development and commercialisation of drugs and therapies; business management services relating to commercialisation of technology, processes and products; promoting public awareness in the field of cancer research; advisory, consultancy, management and organisational services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services] and 42 [Scientific services and related research services; scientific research; chemistry research; medical research; scientific and medical research and development; product development; scientific research and product development in the field of pharmaceuticals and biotechnology; research and development of pharmaceuticals for the treatment of cancer; medical research in the field of oncology; scientific research for medical purposes in the field of cancerous diseases; laboratory research and analysis; pharmaceutical research; drug development; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; assessing the safety and efficiency relating to pharmaceuticals; laboratory testing; quality control; advisory and consultancy services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services]
Type of Mark: Word
Date of Acceptance: Feb. 5
Registration Advertised: June 22
For further details contact HWL Ebsworth Lawyers.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2603567.
Disclaimer: Curated by HT Syndication.
